These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Relationship between intratumoral dihydropyrimidine dehydrogenase activity and gene expression in human colorectal cancer. Uetake H; Ichikawa W; Takechi T; Fukushima M; Nihei Z; Sugihara K Clin Cancer Res; 1999 Oct; 5(10):2836-9. PubMed ID: 10537350 [TBL] [Abstract][Full Text] [Related]
9. [Dihydropyrimidine dehydrogenase and thymidylate synthase in colon carcinoma]. Hamaji M; Nishida T; Miyazaki S; Nishida Y Gan To Kagaku Ryoho; 2002 Jun; 29(6):889-93. PubMed ID: 12090040 [TBL] [Abstract][Full Text] [Related]
10. Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene. van Kuilenburg AB; Haasjes J; Richel DJ; Zoetekouw L; Van Lenthe H; De Abreu RA; Maring JG; Vreken P; van Gennip AH Clin Cancer Res; 2000 Dec; 6(12):4705-12. PubMed ID: 11156223 [TBL] [Abstract][Full Text] [Related]
11. Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers. Baba H; Teramoto K; Kawamura T; Mori A; Imamura M; Arii S Cancer Chemother Pharmacol; 2003 Dec; 52(6):469-76. PubMed ID: 13680162 [TBL] [Abstract][Full Text] [Related]
12. Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. McLeod HL; Sludden J; Murray GI; Keenan RA; Davidson AI; Park K; Koruth M; Cassidy J Br J Cancer; 1998; 77(3):461-5. PubMed ID: 9472644 [TBL] [Abstract][Full Text] [Related]
13. [Expression of dihydropyrimidine dehydrogenase in primary colorectal cancer and liver metastasis--a relationship between mRNA levels in cancer cells and protein levels in cancerous tissue and effect of 5-fluorouracil]. Ishibashi K; Sobajima J; Ishiguro T; Ohsawa T; Okada N; Miyazaki T; Yokoyama M; Inokuma S; Ishida H Gan To Kagaku Ryoho; 2009 Nov; 36(12):2232-5. PubMed ID: 20037380 [TBL] [Abstract][Full Text] [Related]
14. [Dihydropyrimidine dehydrogenase gene expression in patients with hepatic metastases from colorectal cancer]. Shirota Y; Ichikawa W; Yamada H; Uetake H; Nihei Z; Sugihara K Gan To Kagaku Ryoho; 1999 Oct; 26(12):1729-31. PubMed ID: 10560382 [TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of determinations of dihydropyrimidine dehydrogenase levels in primary and hepatic lesions of colorectal cancer patients]. Ishida H; Hashimoto D; Inokuma S; Takeuchi I; Nakada H; Ohsawa T; Hoshino T; Murata N; Fujioka M; Idezuki Y Gan To Kagaku Ryoho; 2000 Oct; 27(12):1879-82. PubMed ID: 11086435 [TBL] [Abstract][Full Text] [Related]
16. Dihydropyrimidine dehydrogenase activity of cancerous and non-cancerous tissues in liver and large intestine. Ikeguchi M; Hirooka Y; Makino M; Kaibara N Oncol Rep; 2001; 8(3):621-5. PubMed ID: 11295091 [TBL] [Abstract][Full Text] [Related]
17. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Engelhardt M; Drullinsky P; Guillem J; Moore MA Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582 [TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients. Amatori F; Di Paolo A; Del Tacca M; Fontanini G; Vannozzi F; Boldrini L; Bocci G; Lastella M; Danesi R Pharmacogenet Genomics; 2006 Nov; 16(11):809-16. PubMed ID: 17047489 [TBL] [Abstract][Full Text] [Related]
19. Dihydropyrimidine dehydrogenase (DPD) and clinical pharmacology of 5-fluorouracil (review). Milano G; Etienne MC Anticancer Res; 1994; 14(6A):2295-7. PubMed ID: 7825962 [TBL] [Abstract][Full Text] [Related]